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UCHL1 (ubiquitin carboxyterminal hydrolase 1) is a deubiquitinating enzyme that is
particularly abundant in neurons. From studies of a spontaneous mutation arising in a
mouse line it is clear that loss of function of UCHL1 generates profound degenerative
changes in the central nervous system, and it is likely that a proteolytic deficit contributes
to the pathology. Here these effects were found to be recapitulated in mice in which
the Uchl1 gene had been inactivated by homologous recombination. In addition to
the previously documented neuropathology associated with loss of UCHL1 function,
axonal swellings were detected in the striatum. In agreement with previously reported
findings the loss of UCHL1 function was accompanied by perturbations in ubiquitin pools,
but glutathione levels were also significantly depleted in the brains of the knockout
mice, suggesting that oxidative defense mechanisms may be doubly compromised. To
determine if, in addition to its role in the central nervous system, UCHL1 function is
also required for homeostasis of the enteric nervous system the gastrointestinal tract
was analyzed in UCHL1 knockout mice. The mice displayed functional changes and
morphological changes in gut neurons that preceded degenerative changes in the brain.
The changes were qualitatively and quantitatively similar to those observed in wild type
mice of much greater age, and strongly resemble changes reported for elderly humans.
UCHL1 knockout mice should therefore serve as a useful model of gut aging.
Keywords: ubiquitin, deubiquitinating enzyme, aging, enteric nervous system, glutathione
INTRODUCTION
UCHL1 is a member of the ubiquitin carboxyterminal hydro-
lases, a subgroup of the deubiquitinating enzymes. UCHL1 was
first detected as an abundant protein in the human brain by two-
dimensional gel analysis. It was estimated that PGP9.5 (as the
protein was originally designated) constituted 1–2% of soluble
brain protein. Based on its abundance and restricted expression
UCHL1 has been used extensively as a pan-neuronal marker (later
studies revealed the expression of UCHL1 is not limited to neu-
rons). The discovery of UCHL1 and much of the later literature
on neuronal and non-neuronal expression has been admirably
reviewed (Day and Thompson, 2010).
The structure and biochemical activities of UCHL1 can be
considered unusual. Like UCHL3 (a closely related but ubiq-
uitously expressed enzyme) UCHL1 has a “knotted” structure
which when projected on a plane displays five crossings (Virnau
et al., 2011). The catalytic domain of UCHL1 differs from that
of UCHL3 by the presence of a loop covering the active site
(Das et al., 2006). In the absence of any conformational change
this loop would obstruct access of any ubiquitinated substrate
larger than a small peptide, which would explain the restriction of
UCHL1 to such substrates in vitro (Larsen et al., 1998). Two pos-
sibilities (which are not mutually exclusive) exist for the in vivo
activity of the enzyme: UCHL1 cleaves ubiquitin from an as yet
unidentified bulky substrate following conformational change, or
the substrates are genuinely small. Proposed roles for UCHL1
are the processing of the ubiquitin proprotein by cleavage of the
short C terminal peptide, and salvage of ubiquitin from rem-
nants of proteasomal degradation proteins. Both activities have
been demonstrated in vitro (Larsen et al., 1998). Both activities
would be essential for maintenance of ubiquitin pools and prote-
olytic efficiency in neurons, and it has been demonstrated that in
the absence of UCHL1 neuronal ubiquitin pools are significantly
depleted (Osaka et al., 2003). In addition to cleaving ubiquitin-
peptide bonds UCHL1 very efficiently cleaves ubiquitin-thioester
bonds (Larsen et al., 1998), suggesting an intriguing possibility for
the homeostatic function of the enzyme. Glutathione is a small
cysteine-containing tripeptide of established relevance to neu-
ronal homeostasis (Shaw, 1998). In a 1983 publication Irwin Rose
and JessieWarms documented the thioesterase activity of UCHL1
(Rose and Warms, 1983) and speculated that this activity may
serve to salvage ubiquitin from spontaneous thioesters formed
with glutathione (a speculation repeated in Rose’s Nobel prize
lecture of 1994). An obvious mechanism for formation of these
conjugates would be transthioesterification with glutathione sup-
planting the E2 conjugating enzymes or E3 ligases of the ubiquitin
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cascade. To our knowledge this activity has not been documented
in vivo. To determine if UCHL1 provides this function in vivo we
assayed ubiquitin and glutathione levels in the nervous system of
our newly generated line of UCHL1 knockout mice and their wild
type littermates.
Much of what is known of UCHL1 function in vivo has been
determined through analysis of GAD (gracile axonal dystrophy)
mice, in which spontaneous deletion of exons 7 and 8 removes
essential domains of the enzyme (Saigoh et al., 1999). GAD
mice show progressive loss of hind limb function associated with
axonal swellings in the gracile tract of the spinal cord. Neurons
with the long processes are most affected, and there is a “dying
back” from distal regions of the axon toward the cell body (Miura
et al., 1993). Because rare polymorphisms in the human UCHL1
gene (also known as PARK5) have been associated with altered
risk for Parkinson’s disease (Wintermeyer et al., 2000;Maraganore
et al., 2004) we examined dopaminergic neuronal projections in
the striatum of UCHL1 null mice. In Parkinson’s disease and
other neurodegenerative conditions the dysfunction seen in CNS
neurons similarly affects those in the periphery, and it is therefore
reasonable to assume that the absence of UCHL1would also affect
neuronal populations outside the CNS. The enteric nervous sys-
tem (ENS) is comprised of a vast and highly organized network
of neurons and glial cells orchestrating gastrointestinal motility,
secretion, and absorption. UCHL1 is abundantly expressed in the
two major ganglionated plexuses that comprise the ENS (Grundy
and Brookes, 2012), but has not been studied in the context of
ENS homeostasis. The gastrointestinal function of UCHL1 null
mice and wild type littermate controls was therefore analyzed
functionally and the ENS of these animals was examined for signs
of neuropathology.
MATERIALS AND METHODS
GENERATION OF UCHL1 KNOCKOUT MICE
The mouse UCHL1 gene was cloned from a 129sv phage
genomic library using methods that have been previously
described (Di Fruscio et al., 1998). A 16 kb region of the gene
spanning the fourth exon was used to generate the target-
ing vector pDG250 (represented schematically in Figure 1), in
which the exon was replaced with the selectable marker pgk-
neo-pgk phosphoglycerate kinase promoter/neomycin phospho-
transferase/phosphoglycerate kinase 3′ untranslated region. The
pDG250 vector was linearized using NotI and transfected in
R1 ES cells (the gift of Andras Nagy, University of Toronto)
via electroporation. Clones resistant to G418 (Geneticin, Life
Technologies, Burlington, Ontario, Canada) were screened for
the desired recombination event by Southern blotting of BstxI
digested DNA using a genomic probe derived from the third
intron. Chimeras were produced by the aggregation of properly
recombined clones with CD-1 morulas and germ line trans-
mission was established. The 129 line was established by cross-
ing the chimera with a 129S1/SvImJ female and is maintained
by intercrossing heterozygous offspring. A second line in the
C57BL/6J genetic background was established by backcrossing
to a C57BL/6J (The Jackson Laboratory, Bar Harbor, Maine,
USA) for 10 generations before intercrossing the heterozygous
offspring.
FIGURE 1 | Generation of UCHL1 null mice. (A) Schematic of the
mutational strategy. A region spanning exon 4 of the mouse UCHL1 gene
was chosen for gene targeting. Through homologous recombination a
portion of the exon including the catalytically essential cysteine at position
90 (asterisk) was replaced with a Pgk-neo-pgk selectable marker. (B)
Confirmation of gene targeting. A probe generated from an intronic
fragment detected the expected 16 kilobase fragment in Southern blotting
analysis of wild type genomic DNA digested with the restriction
endonuclease BstxI. Introduction of an additional cleavage site in the
selectable marker generated a smaller 9 kilobase DNA fragment in genomic
DNA from a G418-resistant embryonic stem cell clone, confirming that one
copy of the UCHL1 gene had been targeted. This clone was used to
generate the UCHL1 knockout line. (C) UCHL1 immunoreactivity in the
dentate gyrus of a wild type mouse. In wild type mice UCHL1
immunoreactivity could be detected throughout the central nervous
system; staining of the dentate gyrus was representative of other regions.
(D) Absence of UCHL1 immunreactivity in the dentate gyrus of a UCHL1
null mouse. This mouse was a littermate of the mouse in (C) (both were
products of a heterozygous cross). Scale bars = 100 microns.
WESTERN BLOTTING
Proteins from freshly dissected tissues were solublized in pro-
tein lysis buffer (20mM Tris-HCl pH 7.5, 150mM NaCl, 1%
Nonidet P-40 (Sigma, St. Louis, Missouri, USA), 0.5mM EDTA,
20% glycerol) containing the following protease and phosphates
inhibitors: 1mM phenylmethylsulfonyl fluoride, 5μg/mL leu-
peptin (Sigma, St. Louis, Missouri, USA), 2μg/mL aprotinin
(Sigma, St. Louis, Missouri, USA), 200μM sodium Fluoride
(NaF) and 200μM sodium pyrophosphate (NaPPi). The cells
were incubated on ice for 30min and then centrifuged at 14
000 rpm for 20min at 4◦C to pellet cellular debris. The soluble
fractions were recovered and the protein concentration was deter-
mined using the Bradford protein assay (Bio-Rad Laboratories
Inc., Mississauga, Ontario, Canada). Twenty or thirty micro gram
of cytoplasmic extracts were then resolved on a two-phase SDS-
polyacrylamide gel (15 and 8%) and electroblotted onto a hybond
C nitrocellulose membrane (Amersham Pharmacia Biotech, Baie
D’Urfé, Québec, Canada). The membranes were stained with
Ponceau S (Sigma, St. Louis, Missouri, USA) prior to western
blotting with the appropriate antibody to ensure the complete
transfer of the proteins. The primary anti-ubiquitin antibody
(DAKO Diagnostics Canada Inc., Burlington, Ontario, Canada)
and secondary anti-rabbit antibody were diluted in 5% skim
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milk in TBST (10mM Tris-HCl (pH7.6), 150mM NaCl and
1% Tween-20) for 1 h at room temperature. The membranes
were washed 3 times with TBST prior to incubation with the
appropriate secondary antibody. The proteins were detected by
a horseradish peroxidase method and SuperSignal West Pico
Chemiluminescent Substrate reagents (Pierce, Rockford, IL, USA)
and were visualized using a GeneGnome instrument (Syngene,
Frederick, Maryland, USA).
IMMUNOHISTOCHEMISTRY
Brains from age-matched wild type and UCHL1 knockout mice
were excised and fixed in 10% phosphate-buffered formalin for
2 days at room temperature. Tissues were paraffin-embedded
and sectioned coronally using a microtome at a thickness of
5μm. Deparaffinized sections were heated in a solution of
10mM sodium citrate (pH 6.0) in 700 W microwave for 10min.
Endogenous peroxidase activity was blocked by incubating in
methanol containing 3% hydrogen peroxide for 20min. Sections
were washed with 0.1M PBS (pH 7.4) and incubated for 30min
with 1.5% normal rabbit, goat, or horse serum (Santa Cruz
Biotechnologies Inc, SC, CA, USA) as appropriate to block
non-specific binding. Sections were then incubated overnight
at 4◦C with the antibody specific for UCHL1 (EMD Millipore,
Darmstadt, Germany) or ubiquitin (DAKO Diagnostics Canada
Inc., Burlington, Ontario, Canada). Sections of the striatum were
stained with an anti-tyrosine hydroxylase antibody (Immunostar,
Hudson,WI, USA) at a dilution of 1:4000. Reaction products were
visualized with the ABC system (DAKO Diagnostics Canada Inc.,
Burlington, Ontario, Canada).
GLUTATHIONE ANALYSIS
For analysis of glutathione levels in vivo 129sv UCHL1-KO
mice were sacrificed at 3 months of age. The animals were dis-
sected and the hindbrains and/or transverse colon collected. The
total glutathione content of the organs was evaluated colori-
metrically using a gluthathione assay kit (Cayman Chemical,
Ann Arbor Michigan, USA) as per the method of Baker (Baker
et al., 1990) and of Tietze (Tietze, 1969). Briefly, samples were
homogenized in MES (2-(N-morpholino)ethanesulphonic acid)
buffer and proteins as well as protein complexes were pre-
cipitated out of solution with metaphosphoric acid. With the
proteins precipitated, remaining thiols in the sample were pre-
sumed to be glutathione. After the sample pH was re-established
with triethanolamine, DTNB (5,5′-dithio-bis-2-(nitrobenzoic
acid), Ellman’s reagent) was added and conjugates to reduced
glutathione (GSH) produced yellow colored TNB (5-thio-2-
nitrobenzoic acid). Glutathione reductase present in solution
ensured all oxidized glutathione (GSSG) was reduced to GSH,
making the test a measure of the total free glutathione (i.e., not
bound to protein) in the sample. Samples were analyzed on an
MRX microplate reader (Dynex Technologies, Chantilly Virginia,
USA) using the instrument’s Revelation software (version 3.04).
For analysis of glutathione in cultured cells NIH3T3 cells
(ATCC, Manassas Virginia, USA) were plated at 8,000 per well
in an opaque 96-well plate. After 24 h, the cells were transfected
with 0.5μg of either plasmid pDG268 (a wild-type ubiqui-
tin/eGFP fusion Tsirigotis et al., 2001b) or pcDNA control using
the GeneJuice transfection reagent (EMDBiosciences, Darmstadt,
Germany). At 48 h, LDN-91946 (3-Amino-2-benzoyl-6-oxo-
6,7-dihydrothieno[2,3-b]pyridine-5-carboxylic acid), a selective,
uncompetitive inhibitor of UCHL1 (Mermerian et al., 2007), was
dissolved in DMSO and added to cells at 25μM and buthionine
sulfoximine (BSO) to other wells at 200μM. At 72 h, cell culture
media was removed, the cells were washed in PBS and the reduced
glutathione (GSH) content of these cells was measured using a
GSH-Glo Glutathione Assay (Promega, Madison WI, USA) on a
Glo-Max luminometer (Promega, Madison Wisconsin, USA).
WHOLE MOUNT ANALYSIS
Wholemounts of the myenteric plexus in the ileum of null, het-
erozygous and wildtype littermates were prepared as previously
described for the mouse colon (Gamage et al., 2013). Ileum sam-
ples were removed and placed for 20min in PBS containing the
calcium channel blocker nicardipine hydrochloride (10−6 mol
L−1) to ensure maximal (and hence comparable) smooth muscle
relaxation. Specimens were then opened longitudinally along the
mesentery and circumference (C) and length (L) were measured.
Specimens were stretched maximally (but without tearing of tis-
sue), pinned on Sylgard-lined plates and fixed for 24 h at room
temperature in modified Zamboni’s fixative (2% paraformalde-
hyde, 0.2% picric acid in 0.1molL−1 sodium phosphate buffer,
pH 7.4). Samples were then washed in 100% dimethyl sulphox-
ide (DMSO) for 3 × 10min followed by 3 × 10min washes in
PBS. The circumference (C′) and the length (L′) were then re-
measured. Themuscularis externa was separated from underlying
layers under a dissecting microscope, the circular muscle layer
was removed and wholemounts of the longitudinal muscle with
myenteric plexus attached were prepared. Wholemounts were
then incubated in PBS pH7.4 containing lysine 1mg/ml, 0.01%
bovine serum albumin, 0.05% sodium azide (antibody dilut-
ing solution, ABDS) and 0.5% Triton × 100 (to aid antibody
penetration), for 2 h at room temperature, followed by 10% nor-
mal goat serum (Dako) in ABDS with 0.1% Triton × 100 for
2 h at room temperature to reduce non-specific binding of anti-
bodies. Wholemounts were incubated overnight (18 h) at room
temperature in rabbit anti PGP 9.5 (Ultraclone, RA95101. 1:) or
anti-nNOS (ImmunoStar, Inc; 24287, 1:1000) antibodies, washed
in PBS (3 × 10min), then incubated in secondary antibodies
(Invitrogen, Goat anti Rabbit Alexa 488, 1:200) in darkness at
room temperature for 2 h. Wholemounts were then washed in
PBS (3 × 10min) and mounted with Citifluor (Agar Scientific
Limited).
QUANTIFICATION OF nNOS-IR NEURONAL NUMBERS
To obtain quantitative data on nNOS–IR neuronal numbers, 7
random confocal Z stacks (1024 × 1024 pixels; optical section
2μm) per specimen were captured using a confocal laser scan-
ning microscope (Leica DM6000 CS) equipped with a 20X objec-
tive, which defined an area of (775 × 775μm2) on the specimen.
Aerial images for each of the 7 random areas were obtained by
overlaying optical sections of the respective Z stack. Quantitative
analysis of images was performed by an experimenter blind to
the tissue from which the images were taken. For each of the 7
images obtained per wholemount, the total number of neurons
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labeled by nNOS antibody was counted using Image Pro Plus
software (Media Cybernetics Inc, Bethesda, MD, USA). nNOS-IR
neurons counted on all 7 images of a wholemount were pooled to
obtain the total neuronal count for that wholemount. Only neu-
rons lying within the optical field and those intersecting the top
and right hand edges were counted. The number of neurons per
unit area varies with the stretch of the wholemount. Therefore,
a correction factor for stretch was employed. The stretch correc-
tion factor was calculated [C× L]/[C′ × L′] for each wholemount
and then the actual unstretched area (A) of the wholemount rep-
resented by 7 images was calculated [stretch correction factor ×
stretched area sampled = stretch correction factor × 4.20mm2].
To obtain the stretch-corrected number of neurons/mm2, each of
the pooled neuronal counts obtained above were divided by the
actual unstretched area (A) of the respective wholemount.
TRANSIT TIME ANALYSIS
Transit time was measured using methodology described by Kuo
et al. (2010).Mice were single caged 1 day prior to the experiment.
At a recorded time mice were gavaged with 0.2ml of carmine dye
(6% w/v: Sigma-Aldrich Canada Co., Oakville, Ontario, Canada)
in 0.5% methyl cellulose (Sigma-Aldrich Canada Co., Oakville,
Ontario, Canada). The gavage needle was dipped in a solution of
1 g/ml sucrose prior to introducing it to the mouse (for a calm-
ing effect). The cage bedding was changed to a white piece of Iso
Pad (Omni Bio Resources, Cherry Hill, New Jersey, USA) to facil-
itate the observation of colored feces. The time at which the first
colored pellet was seen was recorded and the transit time was cal-
culated as the interval between gavage and appearance of the first
colored stool. Data were analyzed for significance by Student’s
t-test.
RESULTS
INACTIVATION OF THE Uchl1 GENE RESULTS IN NEURODEGENERATION
Genomic DNA spanning the fourth exon of the UCHL1 gene
(encoding an essential cysteine at position 90) was isolated from
a 129sv genomic library and was used to generate a targeting
vector in which part of the exon was replaced with a selectable
marker (Figure 1A). An embryonic stem cell clone was identi-
fied in which the expected homologous recombination event had
occurred (Figure 1B). This clone was used to generate a knock-
out line in the 129sv genetic background. Whereas the UCHL1
protein was abundant in wild type brains it was undetectable
in sections from mice homozygous for the targeted gene ana-
lyzed by immunohistochemistry (Figures 1C,D). UCHL1 protein
could not be detected in lysates from the spinal cords of homozy-
gous mice (Figure 3A), nor could the Uchl1 transcript could be
detected by reverse transcriptase/polymerase chain reaction (not
shown). It is probable that the presence of the selectable marker
destabilizes the Uchl1 gene transcript, but with no RNA or pro-
tein product detectable we conclude that the targeting event has
generated a true null mutation. By crossing our original line with
C57BL/6J mice for more than 10 generations a second UCHL1
knockout line in the C57BL/6J background was produced. At the
molecular level these lines are indistinguishable.
Both lines of UCHL1 null mice manifest neurodegenera-
tive phenotypes strongly reminiscent of the GAD spontaneous
mutant (Yamazaki et al., 1988). Mice homozygous for the null
mutation can be identified as early as 6 weeks of age by the fail-
ure to spread their hindlimbs when suspended by the tail (in
this and other behavioral assays heterozygous mice are indistin-
guishable from wild type animals). At various ages the UCHL1
mice have comparable performance on a rotating rod (data not
shown) to that reported for GAD mice (Yamazaki et al., 1992).
With regard to weight all three genotypes are indistinguishable at
12 weeks of age at which point null mice plateau and are sacrificed
when the differential between their weight and healthy littermates
reaches 20%.
Examination of histological sections of the CNS of UCHL1
null mice revealed pathology similar to that reported for GAD
mice, including axonal swellings in the gracile nucleus and in the
cerebellar peduncles (not shown). Our examination was extended
to the striatum, which contains processes from dopaminergic
neurons in the substantia nigra and could therefore be analyzed
to detect a “dying back” phenomenon. Multiple axonal swellings
that stained positive for tyrosine hydroxylase (TH) were detected
in coronal sections of striatum from 3-month old UCHL1 null
mice show (Figure 2). These swellings were almost non-existent
in wild type littermate controls. The difference was found to be
significant (p < 0.005).
UCHL1 IS REQUIRED FOR MAINTENANCE OF UBIQUITIN AND
GLUTATHIONE POOLS
Through a non-catalytic mechanism UCHL1 binds to and stabi-
lizes monomeric ubiquitin (Osaka et al., 2003). In light of this
activity it is to be expected that the total ablation of UCHL1 pro-
tein would result in a reduction in monomeric ubiquitin pools,
a prediction borne out by western blot analysis of spinal cord
lysates (Figure 3A). These data were in agreement with immuno-
histochemical analysis of total ubiquitin in various regions of
the brain, including the gigantocellular nucleus (Figures 3B,C).
An activity that has been postulated for UCHL1 but not pre-
viously demonstrated in vivo is salvage of glutathione from the
ubiquitin-glutathione thioester adducts known to be promiscu-
ously generated in cells (Rose and Warms, 1983). The null mice
provide an appropriate platform for testing the hypothesis that
UCHL1 provides the salvage function. Free glutathione (oxidized
and reduced) was found to be markedly decreased (86%, p <
0.002) in the brains of mice null for UCHL1 as compared to wild
type littermates (Figure 4A). No significant difference was found
between heterozygous and wild type mice. To account for differ-
ences in total protein content and brain size, Bradford assays were
performed on the samples prior to glutathione quantification.
Hindbrain protein content was found to be comparable across
genotypes (data not shown). Glutathione assays were also per-
formed on gut tissues, but no significant difference was detected
between knockout mice and wild type littermates (not shown).
Given the small contribution of ENS cells to the mass of the GI
tract (relative to smooth muscle and secretory cells) it is likely
that any difference in ENS glutathione would be obscured by non-
neuronal sources of the tripeptide and rendered undetectable.
Future studies will attempt to explore the effects of UCHL1
ablation on the glutathione pools of primary cultures of enteric
neurons isolated from the gut, but at present our data are limited
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FIGURE 2 | Example of CNS pathology associated with UCHL1
ablation. Tyrosine hydroxlase (TH) positive axonal swellings in the striatum
of 3-month old UCH-L1 mice. (A,B) are representative images from wild
type mice. (C,D) are representative images from UCHL1 null littermates.
Arrows indicate the position of axonal swellings. Scale bars = 20 microns.
(E) Number of TH positive axonal swellings present in 5 high-power fields
(captured with 40x objective) per mouse (n = 3 for wild type; n = 4 for
UCHL1 null). Error bars represent the standard error of the mean. The
difference between wild type and null mice was found to be significant
(p < 0.005).
to the CNS and effects on ENS glutathione pools seem plausible
but are entirely speculative.
The availability of a pharmacological inhibitor of UCHL1
(Mermerian et al., 2007) allowed us to corroborate the glu-
tathione effect in cultured cells. NIH3T3 cells transfected with
an empty pcDNA control plasmid followed by treatment with
uncompetitive UCHL1 inhibitor LDN-91946 showed a signif-
icant decrease (p < 0.05) in reduced glutathione (GSH) when
compared to cells similarly transfected but without inhibitor
treatment (Figure 4B). To determine the limiting entity in
glutathione-ubiquitin thioester formation ubiquitin levels were
augmented by transfecting cells with pDG268, an expression
vector encoding a ubiquitin-eGFP. In transfected cells the
ubiquitin-eGFP fusion protein is co-translationally processed
FIGURE 3 | Reduction in ubiquitin pools in UCHL1 null mice.
(A) Western blot analysis of protein levels in the brain of a wild type mouse
and the spinal cords (sc) of heterozygous (het), UCHL1 null, and wild type
littermates from a heterozygous cross. No UCHL1 protein was detectable
in the lysate of the null animal, coincident with a reduced level of
monomeric ubiquitin. Beta actin levels appeared equivalent, consistent with
equal loading. (B) Ubiquitin immunoreactivity in the gigantocellular reticular
nucleus of a wild type mouse. (C) Reduced ubiquitin immunoreactivity in
the gigantocellular reticular nucleus of a UCHL1 null mouse a littermate of
the wild type mouse in panel (B). Scale bars = 100 microns.
by deubiquitinating enzymes to produce functional monomeric
ubiquitin (Tsirigotis et al., 2001a). Expression of the eGFP com-
ponent was confirmed by fluorescence microscopy of transfected
cells (not shown). No significant difference was detected in the
GSH levels of cells transfected with pDG268 vs. cells trans-
fected with the empty pcDNA plasmid (Figure 4B), indicating
that pre-existing ubiquitin pools did not limit thioester forma-
tion. Buthionine sulfoximine (BSO) inhibits glutamate-cysteine
ligase, the initial enzyme in glutathione biosynthesis. It there-
fore provides an effective control for glutathione measurement.
With the addition of BSO we observed near total depletion of the
glutathione pool (p < 0.001).
MORPHOLOGICAL ABNORMALITIES IN THE ENS OF Uchl1 KNOCKOUT
MICE RESEMBLING THOSE OF AGED ANIMALS
The ENS of Uchl1 knockout, heterozygous and wildtype litter-
mates was studied in wholemount preparations of the myen-
teric plexus of the ileum by immunofluorescence techniques.
Wholemounts were immunolabeled for UCHL1 using anti PGP
9.5 antiserum (UCHL1 is also known as protein gene product
9.5, or PGP 9.5, see 1). Previous studies have shown that PGP
9.5 immunoreactivity is detected in almost all myenteric neuronal
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FIGURE 4 | Reduction in glutathione levels in the absence of UCHL1
activity. (A) Free glutathione levels (GSH/GSSG) in mouse hindbrain.
Shown are the average level of glutathione for each genotype (n = 8 for
UCHL1 null, n = 2 for heterozygous, n = 6 for wild type) normalized to the
average levels of wild type littermates (set at 100%). Error bars represent
the standard deviation. ∗p < 0.005. (B) Reduced glutathione (GSH) levels in
NIH3T3 cells treated with LDN-91946. A pharmacological inhibitor of
UCHL1. Shown are the average GSH levels normalized to the average of
control cells transfected with the empty pcDNA vector (set at 100%). Error
bars represent the standard deviation. ∗p < 0.05 (Ub = 0.017, pcDNA =
0.025) ∗∗p < 0.001 (BSO = 0.000538).
cell bodies and in nerve fibers, and it has been widely used as a
pan-neuronal marker in the ENS. As expected, no immunore-
activity was detected in the ENS of knockout mice (compare
Figures 5A,B).
To study the effect of UCHL1 knockout on the morphology
of myenteric neurons, one of the major subpopulations of myen-
teric neurons, nitrergic neurons, was chosen for analysis. We
chose to concentrate our studies on the ileum because the ENS
is better characterized in that region than in other gut regions,
FIGURE 5 | ENS pathology associated with UCHL1 ablation. (A) PGP
9.5 (UCHL1) immunoreactivity in wildtype mouse ileum. Myenteric ganglia
linked by nerve fiber bundles are clearly visible. Immunoreactive neuronal
cell bodies and nerve fibers can be seen in the ganglia and thinner parallel
nerve fiber bundles in the tertiary plexus (which innervates the longitudinal
muscle layer) are also present. Scale bar = 100 microns (B) Lack of PGP 9.5
immunoreactivity in null mouse ileum. Scale bar = 100 microns (C) nNOS
immunoreactive neurons and nerve fibers in the myenteric ganglia and
fibers in the tertiary plexus of wildtype mouse ileum. Scale = 100 microns
(D) nNOS immunoreactive neurons and nerve fibers in the myenteric
ganglia and fibers in the tertiary plexus of null mouse ileum. Fibers in the
tertiary plexus and ganglia appear larger and brighter than in those in
Figure 5D. Scale = 100 microns (E) Higher magnification showing swollen
nNOS immunoreactive fibers (yellow arrows) in the tertiary plexus and
myenteric ganglion of a null mouse ileum. Scale bar = 20 microns (F)
Density of nNOS immunoreactive neurons in the myenteric plexus of null
(KO) and wildtype mouse ileum. No significant difference in neuronal
numbers was detected by Mann–Whitney test. Raw cell counts were
corrected for varied stretch of the wholemounts.
including other regions of the small intestine. Nitrergic neurons
constitute approximately 26% of the total myenteric population
in the mouse ileum (Qu et al., 2008), and they play a key role in
smooth muscle relaxation, and hence in gastrointestinal motility.
Nitrergic neurons in wholemount preparations were immunola-
beled using an antiserum raised against nNOS (neuronal nitric
oxide synthase). Immunolabeling of nNOS in knockout and
in wild-type littermates is shown in Figures 5C,D. No change
in the appearance of neuronal cell bodies was observed, but
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numerous swollen process were seen in the knockout animals
(Figure 5E). These swellings resemble those seen in the ENS of
ageing mice (Gamage et al., 2013). There was no change in the
number of nNOS-IR myenteric neurons in either the knock-
out or heterozygous mice, when compared to wildtype controls
(Figure 5F). Neither was there a large scale atrophy; measure-
ment of ileum circumference prior to whole mount preparation
failed to reveal difference in mice of the various genotypes (not
shown).
EVIDENCE FOR REDUCED GI FUNCTION IN Uchl1 KNOCKOUT MICE
AND IN AGED CONTROL MICE
The structural abnormalities detected in the ENS of mice null for
UCHL1 suggested that gastrointestinal function may be altered
in these mice. Dysfunction of the myenteric plexus would be
expected to compromise the smooth muscle relaxation and/or
contraction orchestrated within the ENS, culminating in a motil-
ity deficit. To determine if this was the case we measured the
transit time for a bolus of colored dye introduced into the stom-
ach to be expelled by defecation. Transit times were measured for
male and female cohorts of homozygous null mice and wild type
littermates in both the 129Sv and C57BL/6J genetic backgrounds.
Data are shown for the C57BL/6J cohorts (Figures 6A,B), but
were similar for the 129Sv mice. We observed an increase of
approximately 40% in the transit time of UCHL1 mice of both
sexes, a difference that was found to be statistically significant.
To determine how this genetically induced deficit in gastroin-
testinal motility compared to “natural” age-related decline we
performed identical transit time analyses in cohorts of young
and older C57BL/ICRFAt1 mice (2 month and 26 months of
age respectively, roughly corresponding 8 and 80 years of age in
the human Turnbull et al., 2003) obtained from the aged rodent
colony at Newcastle University, Newcastle upon Tyne, United
Kingdom. The survival of mice in this colony at 26 months of age
is approximately 50% (see Supplementary Materials). There was
a remarkable concordance in our findings (Figure 6C): genetic
ablation of UCHL1 results in reduced intestinal motility equiv-
alent to that caused by 2 years of aging in the mouse (an interval
that would equate to decades of human aging).
DISCUSSION
The finding that UCHL1 null mice have a progressive neurode-
generative phenotype culminating in hindlimb paralysis was not
unexpected; indeed our intention in eliminating a portion of the
catalytic domain of UCHL1 was to ensure that any protein pro-
duced from the gene would be inactive, as is the case for the
spontaneous deletion of the seventh and eighth UCHL1 exons in
GAD mouse line (Saigoh et al., 1999). Similarly, our finding that
ubiquitin pools are reduced in the absence of the UCHL1 protein
is in good agreement with previous findings (Osaka et al., 2003)
and suggests that perturbation of ubiquitin-mediated proteolysis
in the knockout mice could contribute to their pathology. If so,
the situation could be greatly exacerbated by a diminution of glu-
tathione levels in the nervous system. Glutathione provides a criti-
cal anti-oxidant defence to neurons, as evidenced by the apoptotic
cell death of primary neurons in which glutathione levels have
FIGURE 6 | GI functional changes associated with UCHL1 ablation.
(A) Transit time analysis of wild type and UCHL1 null male mice of the
C57BL/6 genetic background. Mice were 8–12 weeks of age (average 10
weeks). Each symbol represents the transit time for one mouse. The
horizontal line represents the mean transit time value. ∗p < 0.05 (B)
Transit time analysis of wild type and UCHL1 null female mice of the
C57BL/6 genetic background. Mice were 8–12 weeks of age (average 10
weeks). Each symbol represents the transit time for one mouse. The
horizontal line represents the mean transit time value. ∗∗p < 0.0001 (C)
Transit time analysis of young (8 week) and older (26 month) mice of the
C57Bl/ICRFAt1 genetic background Each symbol represents the transit
time for one mouse. The horizontal line represents the mean transit time
value. ∗p < 0.05.
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been reduced pharmacologically (Andersen et al., 1996) or by
knockdown of the rate-limiting enzyme for biosynthesis (Diaz-
Hernandez et al., 2005). Fibroblasts from mice engineered to be
deficient in glutathione by knockout of glutamate-cysteine ligase
are hypersensitive to oxidative damage; mice null for the cat-
alytic subunit of the enzyme die in utero (Dalton et al., 2000).
Based on the existing literature it is unlikely that the 15% reduc-
tion in glutathione levels we have documented in the brains of
UCHL1 knockout mice could alone account for the extensive,
ultimately fatal neurodegeneration in our mice (or in the GAD
mouse line). Rather we speculate that partial depletion of glu-
tathione may compromise anti-oxidative defences sufficiently to
task the ubiquitin-proteasome system with the degradation of an
added burden of oxidatively damaged protein. Over the course of
time the added burden may be particularly problematic for neu-
rons with relentless metabolic demands and limited proteolytic
reserves. Motor neurons with extremely long axonal processes
may fall into this category (perhaps due to the requirement
for active proteolysis at distant synaptic sites, and the incessant
demands for transport of biosynthetic and degradative compo-
nents to these sites). Another potentially vulnerable neuronal
population is dopaminergic neurons within the substantia nigra.
There is evidence that dopamine metabolism imposes an inher-
ent level of oxidative stress that can at least in part explain why the
substantia nigra is a major locus of Parkinson’s disease (Tsang and
Chung, 2009). Swollen striatal axons are found in both the MPTP
(Turner et al., 1988) and α-synuclein overexpression (Decressac
et al., 2011) models of Parkinson’s disease. Nigrostriatal fibers are
not the most abundant striatal afferents but TH-positive axons
originate specifically from the substantia nigra. Nigral degenera-
tion is the hallmark feature of PD and glutathione depletion has
been implicated as a triggering event in PD pathogenesis (Perry
et al., 1982; Jenner et al., 1992; Nakamura et al., 1997). Nigral
dopaminergic neurons have been shown in vivo to be more sen-
sitive to glutathione depletion than non-dopaminergic neurons
(Garrido et al., 2011).
Mechanistically we believe that the best explanation for the
partial glutathione depletion in UCHL1 null mice is afforded by
the salvage pathway (Rose and Warms, 1983). In the absence of
this activity the fate of glutathione would be that of ubiquitin
itself, which is known to turn over through proteosomal degra-
dation (Shabek and Ciechanover, 2010). Remaining glutathione-
ubiquitin conjugates would at a minimum be functionally inert
(the thioester bond blocking the residues through which both
components normally form covalent bonds to substrates), but
the possibility also exists for dominant negative interference
with components of anti-oxidative and/or ubiquitin-mediated
pathways.
Gastrointestinal disorders are among the problems that plague
the elderly, and there has been some effort to determine the extent
to which deterioration of the ENS contributes to the loss of gas-
trointestinal function. Much of this work has been done in model
systems, most notably the guinea-pig, the rat, and the mouse. A
seemingly simple but fundamental question is whether neurons
are lost from the ENS as the organism ages, but simple answers
have not been forthcoming. There is considerable variability in
the figures reported for age-related neuronal cell death in the
ENS of these three species, and even amongst strains of the same
species (Saffrey, 2013). Whereas figures as high as 50% have been
reported for aged Sprague-Dawley rats (Cowen et al., 2000) it
would appear that in the C57BL/6 mouse no neuronal loss occurs
in the myenteric plexus of the colon at ages up to 2 years (Gamage
et al., 2013). The chief finding in the aged mouse is the accumu-
lation of swollen fibers and varicosities within ganglia and in the
fiber bundles that connect ganglia (Gamage et al., 2013). These
abnormalities are very similar to the swellings detected in the
colonic myenteric plexus of UCHL1 knockout mice (Figure 5).
Even in optimal conditions it would be reasonable to assume that
metabolically active ENS neurons would be faced with oxida-
tive damage, and there is evidence that levels of reactive oxygen
species increase with age in the neurons of the myenteric plexus
(Thrasivoulou et al., 2006). The data presented herein demon-
strate that genetic ablation of UCHL1 results in reduced pools
of monomeric ubiquitin and glutathione (Figures 3, 4, respec-
tively). A reduction in the efficiency of protein turnover and
in the chief anti-oxidative defence of ENS neurons may under-
lie their propensity to develop age-related pathological features
precociously.
Within the adult ENS there exist stem cells and/or glia that
can be differentiated into neurons in vitro (Joseph et al., 2011;
Laranjeira et al., 2011). Studies in the adult rat provided no
evidence for neurogenesis in vivo, and at present there is no rea-
son to believe that damaged, dysfunctional, or dead neurons in
the digestive tract are routinely replaced (discussed in Saffrey,
2013). It therefore seems likely that the neurons in the ENS
of a centenarian have persisted for 100 years, attesting to their
robustness in a fortunate subset of individuals. For other elderly
individuals the evidence for gastrointestinal decline is unfortu-
nately inescapable: the elderly are disproportionately represented
amongst patients reporting gastrointestinal distress (Wade and
Cowen, 2004). Transit time analysis have been performed in
human subjects (similar to the studies reported herein, but uti-
lizing radioisotopes rather than dye tracers), and an increase of
very similar magnitude was reported for aging humans (Madsen
and Graff, 2004) as we have reported for aging or UCHL1 null
mice. Even in younger individuals the ENS may be damaged by
parasitic infection (Iantorno et al., 2007) or by anticancer thera-
pies (Wafai et al., 2013) or pharmacological interventions. With
no prospect of replacing aged ENS neurons it would appear that
the preservation of neurons is of paramount importance, but we
still know relatively little about potential promoters of ENS neu-
ronal longevity or even of the molecular mechanisms that can
compromise such longevity. UCHL1 levels are known to be lower
in replaceable CNS neurons of mice and songbirds (Lombardino
et al., 2005); the data presented herein suggest that UCHL1 is
essential for homeostasis of irreplaceable neurons in the ENS.
By providing an accelerated and therefore tractable model of
ENS decline, UCHL1-deficient mice should provide insights into
ENS aging, and may provide a platform for the assessment of
therapeutic interventions to preserve ENS function.
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